Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
CHILDREN'S ONCOLOGY GROUP
Funding Organization
Temporal Graph
Map of Science
Research
Research
Awards Grant
AAML 1031 - A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD
APEC1621SC - PEDIATRIC MATCH PCR - COG FOUNDATION
Children's Oncology Group Long-Term Follow-Up Guidelines
Children's Oncology Group Long-Term Follow-Up Guidelines
Long-Term Follow-Up Center to Facilitate Survivorship Research Within COG
Long-term Follow-up Center to Facilitate Survivorship Research within COG
Project Everychild APEC14B1
